Drug Hunter
Home > Merck IDO1 inhibitor
heme-displacing IDO1 inhibitor
human predicted QD dose of 26 mg
from 260k MS-based screen and SBDD
ACS Med. Chem. Lett. Mar. 10, 2020
Merck, Boston, MA
Merck IDO1 inhibitor (Merck heme-displacing oral IDO1 inhibitor)
You don’t have time to read everything, but you can’t afford to fall behind.
Drug Hunter Premium is drug discovery, distilled, so you can quickly catch up and make informed decisions based on industry examples.
Get ahead now by requesting a trial.
March 2020
Molecules of the Month
01
January
02
February
03
March
04
April
05
May
06
June
07
July
08
August
09
September
10
October
11
November
12
December
MOTY Nominees
Molecule of the Year